Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. Jazz Pharmaceuticals plc

41.1% sales growth and 15.69% return on equity

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally.

Jazz Pharmaceuticals plc’s sales growth this year is anticipated to be 31.6% and 23.9% for next year.

Year-on-year quarterly revenue growth grew by 13.6%, now sitting on 2.44B for the twelve trailing months.

Jazz Pharmaceuticals plc’s sales growth for the next quarter is 41.1%. The company’s growth estimates for the present quarter and the next is 5.7% and negative -15.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.69%.

Volatility

Jazz Pharmaceuticals plc’s last day, last week, and last month’s current volatility was 1.18%, 2.43%, and 1.23%, respectively.

Jazz Pharmaceuticals plc’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.90% (day), 3.39% (last week), and 2.48% (last month), respectively.

Jazz Pharmaceuticals plc’s Stock Yearly Top and Bottom Value

Jazz Pharmaceuticals plc’s stock is valued at $172.84 at 14:22 EST, below its 52-week high of $178.64 and way above its 52-week low of $101.81.

Jazz Pharmaceuticals plc’s Moving Average

Jazz Pharmaceuticals plc’s worth is higher than its 50-day moving average of $165.88 and above its 200-day moving average of $158.76.

3. Semler Scientific

36% sales growth and 63.47% return on equity

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States.

Semler Scientific’s sales growth this year is expected to be 49.1% and 23.6% for next year.

Year-on-year quarterly revenue growth grew by 39.8%, now sitting on 42.36M for the twelve trailing months.

Semler Scientific’s sales growth is a negative 0% for the current quarter and 36% for the next. The company’s growth estimates for the ongoing quarter and the next is 346.2% and 3.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 63.47%.

Volatility

Semler Scientific’s last day, last week, and last month’s current volatility was 0.88%, 1.11%, and 0.89%, respectively.

Semler Scientific’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.98% (day), 3.63% (last week), and 2.53% (last month), respectively.

Semler Scientific’s Stock Yearly Top and Bottom Value

Semler Scientific’s stock is valued at $112.00 at 14:22 EST, under its 52-week high of $118.97 and way above its 52-week low of $33.53.

Semler Scientific’s Moving Average

Semler Scientific’s value is above its 50-day moving average of $106.09 and way higher than its 200-day moving average of $82.72.

4. FactSet Research Systems

5.3% sales growth and 45.74% return on equity

FactSet Research Systems Inc. provides integrated financial information and analytical applications to the investment and corporate communities in the United States, Europe, and the Asia Pacific.

FactSet Research Systems’s sales growth this year is expected to be 6% and 4.7% for next year.

Year-on-year quarterly revenue growth grew by 6%, now sitting on 1.54B for the twelve trailing months.

FactSet Research Systems’s sales growth for the next quarter is 5.3%. The company’s growth estimates for the present quarter and the next is a negative 3.8% and negative -2.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.74%.

Volatility

FactSet Research Systems’s last day, last week, and last month’s current volatility was 1.74%, 1.59%, and 1.46%, respectively.

FactSet Research Systems’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.95% (day), 2.67% (last week), and 2.72% (last month), respectively.

FactSet Research Systems’s Stock Yearly Top and Bottom Value

FactSet Research Systems’s stock is valued at $342.06 at 14:22 EST, below its 52-week high of $365.77 and way above its 52-week low of $266.27.

FactSet Research Systems’s Moving Average

FactSet Research Systems’s worth is above its 50-day moving average of $320.39 and above its 200-day moving average of $323.02.

5. Valmont Industries

18.4% sales growth and 13.09% return on equity

Valmont Industries, Inc. produces and sells fabricated metal products in the United States, Australia, Denmark, and internationally.

Valmont Industries’s sales growth this year is anticipated to be 12.2% and 4.7% for next year.

Year-on-year quarterly revenue growth grew by 14.9%, now sitting on 3B for the twelve trailing months.

Valmont Industries’s sales growth for the next quarter is 18.4%. The company’s growth estimates for the current quarter and the next is 25% and 17.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.09%.

Volatility

Valmont Industries’s last day, last week, and last month’s current volatility was 1.07%, 0.47%, and 1.36%, respectively.

Valmont Industries’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.26% (day), 1.88% (last week), and 2.33% (last month), respectively.

Valmont Industries’s Stock Yearly Top and Bottom Value

Valmont Industries’s stock is valued at $252.87 at 14:22 EST, way below its 52-week low of $98.00.

Valmont Industries’s Moving Average

Valmont Industries’s worth is above its 50-day moving average of $237.56 and way above its 200-day moving average of $183.92.

6. STORE Capital Corporation

12.2% sales growth and 4.48% return on equity

STORE Capital Corporation is an internally managed net-lease real estate investment trust, or REIT, that is the leader in the acquisition, investment and management of Single Tenant Operational Real Estate, which is its target market and the inspiration for its name.

STORE Capital Corporation’s sales growth this year is anticipated to be 11.8% and 10.2% for next year.

Year-on-year quarterly revenue growth grew by 3.3%, now sitting on 697.17M for the twelve trailing months.

STORE Capital Corporation’s sales growth is a negative 0% for the ongoing quarter and 12.2% for the next. The company’s growth estimates for the present quarter and the next is a negative 15.4% and 43.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.48%.

Volatility

STORE Capital Corporation’s last day, last week, and last month’s current volatility was 0.39%, 0.64%, and 0.63%, respectively.

STORE Capital Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.34% (day), 1.61% (last week), and 1.68% (last month), respectively.

STORE Capital Corporation’s Stock Yearly Top and Bottom Value

STORE Capital Corporation’s stock is valued at $35.97 at 14:22 EST, below its 52-week high of $36.40 and way above its 52-week low of $16.63.

STORE Capital Corporation’s Moving Average

STORE Capital Corporation’s worth is higher than its 50-day moving average of $34.40 and way above its 200-day moving average of $32.34.

7. Accenture plc.

15.4% sales growth and 31.88% return on equity

Accenture plc provides consulting, technology, and outsourcing services worldwide.

Accenture plc.’s sales growth this year is expected to be 10.9% and 7.5% for next year.

Year-on-year quarterly revenue growth grew by 8.5%, now sitting on 45.68B for the twelve trailing months.

Accenture plc.’s sales growth for the next quarter is 15.4%. The company’s growth estimates for the present quarter and the next is 17.9% and 2.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.88%.

Volatility

Accenture plc.’s last day, last week, and last month’s current volatility was 0.89%, 0.54%, and 0.53%, respectively.

Accenture plc.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.89% (day), 0.91% (last week), and 1.05% (last month), respectively.

Accenture plc.’s Stock Yearly Top and Bottom Value

Accenture plc.’s stock is valued at $291.73 at 14:22 EST, under its 52-week high of $293.42 and way higher than its 52-week low of $174.94.

Accenture plc.’s Moving Average

Accenture plc.’s worth is above its 50-day moving average of $280.37 and way higher than its 200-day moving average of $256.44.

LEAVE A REPLY

Please enter your comment!
Please enter your name here